Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.62M.
ENTERPRISE VALUE (EV)
$1.62M
BioRestorative Therapies, Inc.
Market Cap
$3.14M
Enterprise Value (EV)
$1.62M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | $3.14M | $1.62M |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | $21.33M |
| Aethlon Medical, Inc. (AEMD)vs › | $3.21M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.25M | $3.26M |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | $2.30M |
| Revelation Biosciences, Inc. (REVB)vs › | $2.94M | N/A |
| IceCure Medical Ltd (ICCM)vs › | $2.86M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A |
Market Cap
$3.14M
Total Debt
$0.00
Cash
$1.51M
Enterprise Value
$1.62M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
